About
Treatments for gout and chronic kidney diseases
Areas of Focus
Categories
Small Molecule PharmaceuticalSan Diego & Southern California
Team (5)
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
10
As Collaborator
0
Total Enrollment
1,883
By Phase
PHASE2: 4PHASE3: 2PHASE1: 4
By Status
COMPLETED: 7ACTIVE_NOT_RECRUITING: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07116746Lead Sponsor
Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients
PHASE2Not yet recruiting
25 participants
Started: Sep 30, 2025 · Completed: Jan 31, 2027
NCT06846515Lead Sponsor
Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301)
PHASE3Active, not recruiting
750 participants
Started: Mar 11, 2025 · Completed: Apr 30, 2026
NCT06439602Lead Sponsor
Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)
PHASE3Active, not recruiting
750 participants
Started: Jun 26, 2024 · Completed: Nov 30, 2026
NCT05253833Lead Sponsor
Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout
PHASE2Completed
42 participants
Started: Aug 12, 2022 · Completed: Oct 28, 2024
NCT05119686Lead Sponsor
Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients
PHASE2Completed
140 participants
Started: Nov 16, 2021 · Completed: Nov 17, 2022
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...